2010
DOI: 10.1002/mds.23115
|View full text |Cite
|
Sign up to set email alerts
|

Rare and serious cardiac side effects during ropinirole titration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Extra care should be taken for those patients who are on concomitant medications able to prolong the QT interval or that inhibit the cytochrome, CYP3A4, including, but not limited to, some drugs commonly used in clinical practice, such as omeprazole and ranitidine, or other medications also frequently used in the parkinsonian population, such as sertraline and high‐dose entacapone. Obviously, domperidone should also be avoided in patients with concomitant cardiac diseases, and, in this regard, it is important to remember that serious cardiac side effects have also been associated with the use of nonergot DAs …”
mentioning
confidence: 99%
“…Extra care should be taken for those patients who are on concomitant medications able to prolong the QT interval or that inhibit the cytochrome, CYP3A4, including, but not limited to, some drugs commonly used in clinical practice, such as omeprazole and ranitidine, or other medications also frequently used in the parkinsonian population, such as sertraline and high‐dose entacapone. Obviously, domperidone should also be avoided in patients with concomitant cardiac diseases, and, in this regard, it is important to remember that serious cardiac side effects have also been associated with the use of nonergot DAs …”
mentioning
confidence: 99%